KALA KALA BIO INC revenue, earnings and financials
For the quarter ended June 30, 2026, KALA BIO INC reported revenue of n/a, net income of −$1.58M and diluted EPS of −$21.32; for the fiscal year ended December 2025 revenue was $0.
KALA annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$39.2M, net income −$27.0M (margin n/a), EPS −$3.31
- Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$41.0M, net income −$38.5M (margin n/a), EPS −$10.15
- Fiscal year ended Dec 2023: revenue $0, gross profit n/a, operating income −$39.7M, net income −$42.2M (margin n/a), EPS −$17.35
- Fiscal year ended Dec 2022: revenue $3.89M, gross profit n/a, operating income −$81.7M, net income −$44.8M (margin -1151.6%), EPS −$29.48
- Fiscal year ended Dec 2021: revenue $11.2M, gross profit n/a, operating income −$130M, net income −$143M (margin -1268.7%), EPS −$108.32
KALA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.58M, EPS −$21.32
- Quarter ended Mar 31, 2026: revenue n/a, net income −$1.62M, EPS −$0.14
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income $686K, EPS $153.89
- Quarter ended Sep 30, 2025: revenue n/a, net income −$7.56M, EPS −$1.07
- Quarter ended Jun 30, 2025: revenue n/a, net income −$11.2M, EPS −$85.64
- Quarter ended Mar 31, 2025: revenue n/a, net income −$8.95M, EPS −$70.49
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$8.18M, EPS −$0.86
- Quarter ended Sep 30, 2024: revenue n/a, net income −$8.95M, EPS −$1.93
- Quarter ended Jun 30, 2024: revenue n/a, net income −$9.58M, EPS −$3.16
- Quarter ended Mar 31, 2024: revenue n/a, net income −$11.8M, EPS −$4.20
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$8.63M, EPS −$2.59
- Quarter ended Sep 30, 2023: revenue n/a, net income −$8.70M, EPS −$3.41
- Quarter ended Jun 30, 2023: revenue n/a, net income −$10.4M, EPS −$4.36
- Quarter ended Mar 31, 2023: revenue n/a, net income −$14.5M, EPS −$6.99
- Quarter ended Dec 31, 2022 (from the annual report): revenue $0 (down 100.0% year over year), net income −$12.8M, EPS −$7.63
- Quarter ended Sep 30, 2022: revenue $420K (down 86.3% year over year), net income $29.1M, EPS $19.25
- Quarter ended Jun 30, 2022: revenue $2.10M (down 31.2% year over year), net income −$28.1M, EPS −$18.92
- Quarter ended Mar 31, 2022: revenue $1.37M (down 58.0% year over year), net income −$32.9M, EPS −$22.18
- Quarter ended Dec 31, 2021 (from the annual report): revenue $1.86M, net income −$47.6M, EPS −$85.85
- Quarter ended Sep 30, 2021: revenue $3.07M, net income −$28.1M, EPS −$21.41
KALA cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$32.0M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$29.4M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$27.9M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$78.9M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$108M, share buybacks n/a
KALA balance sheet
- Jun 30, 2026: cash $229K, total assets $10.6M, total liabilities $1.54M, shareholders' equity $9.04M
- Mar 31, 2026: cash $1.76M, total assets $12.3M, total liabilities $1.56M, shareholders' equity $10.8M
- Dec 31, 2025: cash $7.56M, total assets $9.49M, total liabilities $2.49M, shareholders' equity $7.00M
- Sep 30, 2025: cash $21.1M, total assets $25.0M, total liabilities $33.7M, shareholders' equity −$8.67M
- Jun 30, 2025: cash $31.9M, total assets $36.1M, total liabilities $39.3M, shareholders' equity −$3.21M, long-term debt $18.8M
- Mar 31, 2025: cash $42.2M, total assets $48.3M, total liabilities $42.5M, shareholders' equity $5.71M, long-term debt $15.1M
- Dec 31, 2024: cash $51.2M, total assets $55.5M, total liabilities $43.2M, shareholders' equity $12.3M, long-term debt $20.1M
- Sep 30, 2024: cash $49.2M, total assets $54.1M, total liabilities $47.2M, shareholders' equity $6.86M, long-term debt $17.2M
What is KALA's revenue?
KALA BIO INC reported $0 of revenue for the fiscal year ended December 2025.
Is KALA profitable?
No. KALA BIO INC lost $10.1M over the last four quarters.
What is KALA's EPS?
Diluted earnings per share over the last four quarters were $131.36; −$21.32 in the latest quarter.